209 Views | 105 Downloads
Rabindra Tirouvanziam, PhD, Emory Children’s Center, 2015 Uppergate Dr NE, Rm 344, Atlanta, GA 30322, USA, Ph: +1 404 712 7684; tirouvanziam@emory.edu
Experimental conception and design: RT, HMJ, BJS, JDC. Performed experiments: JDC, HH, CM, MBK, MV. Interpreted results and provided critical support: JDC, HH, CM, MBK, HKL, BJS, HAWMT, AJT, LP, LG, KU, YMG, HMJ, DPJ, RT. Prepared manuscript: JDC. Reviewed or edited and approved manuscript: All authors.
We thank the patients and their families for consenting to participate in this study. We acknowledge research coordinators E. Nieuwhof, E. van der Wiel and B. Manai (Erasmus MC-Sophia, Rotterdam, The Netherlands) for their support in recruiting patients. We thank M.W.H. Pijnenburg, J.C. de Jongste, L. Duijts, S. Kloosterman and I.M. de Kleer (Erasmus MC-Sophia, Rotterdam, The Netherlands) for performing bronchoscopies. We thank M. Kemner (Erasmus MC-Sophia, Rotterdam, The Netherlands) for her guidance with PRAGMA-CF scoring. We thank Nina Dickerhof (University of Otago, Christchurch, New Zealand) for insightful technical discussions about the MPO assay method.
Supported by NHLBI F32 HL132493 (J.D. Chandler); Emory Children’s CF and Airways Disease Research Center Startup Fund (J.D. Chandler and M.B. Kilgore); CFF P30 MCCART15R0 (C. Margaroli); NHLBI R01 HL126603 and Common Fund for Metabolomics Supplement HL126603-02S1 (R. Tirouvanziam, A.J. Taurone, L. Peng, H. Horati, H.M. Janssens, B.J. Scholte and M. Veltman); Dutch Cystic Fibrosis Foundation (NCFS) grant HIT-CF 1 and 2 (H. Horati, M. Veltman, B.J. Scholte, H.A.W.M. Tiddens and H.M. Janssens); ERARE INSTINCT (M. Veltman and B.J. Scholte); and P30 ES019776, S10 OD018006 and R01 ES023485 (H.K. Liu, K. Uppal, Y-M. Go and D.P. Jones).
©ERS 2018.